1. |
YOKOYAMA T, MIYAUCHI K, KURATA T. Effect of probucol on neointimal thickening in a stent porcine restenosis model[J]. Jpn Heart J, 2004, 45(2):305-13.
|
2. |
贾伟华,周立春,田桂林. 普罗布考对颈动脉粥样硬化斑块稳定性影响的临床研究[J].中国新药杂志, 2007,16:237-239.
|
3. |
FORTI N, RAMIRES JA. Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study[J]. Arq Bras Cardiol, 1991, 57(3):25361.
|
4. |
JEON SM, PARK YB, KWON OS, et al. Vitamin E supplementation alters HDLcholesterol concentration and paraoxonase activity in rabbits fed highcholesterol diet: comparison with probucol[J]. J Biochem Mol Toxicol, 2005, 19(5):336-46.
|
5. |
HONG SC, ZHAO SP, WU ZH. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SRBI) expression in the liver of hypercholesterolemic rabbits[J]. Int J Cardiol, 2007, 115(1):29-35.
|
6. |
傅 琛,夏强,曹春梅,等.活性氧,NO和线粒体ATP敏感钾通道在TNF2A预处理对缺血/再灌注心肌保护中的作用[J].中国应用生理学杂志,2005,21(1):20-24.
|
7. |
HONG SC, ZHAO SP, WU ZH.Probucol upregulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits[J]. J Cardiovasc Pharmacol, 2006, 47(1):77-81.
|
8. |
顾江涛,屈文昌,张安,丙丁酚对冠心病及其高位人群血管内皮功能失调的作用[J].临床心血管病杂志, 2006,22(2):117-118.
|
9. |
FRUEBIS J, SILVESTRE M, SHELTON D, et al. Inhibition of VCAM1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits[J]. J Lipid Res, 1999, 40(11):1958-66.
|
10. |
ADLOUNI A, EL MESSAL M, SA?LE R. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AIcontaining lipoprotein particles[J]. Atherosclerosis, 2000,152(2):433-40.
|
11. |
SUKHOVA GK, SCH?NBECK U, RABKIN E. Evidence for increased collagenolysis by interstitial collagenases1 and 3 in vulnerable human atheromatous plaques[J]. Circulation, 1999,18; 99(19):2503-9.
|